What is the CVSS score of CVE-2023-41150?

CVE-2023-41150 has a CVSS 3.1 base score of 5.4 (Medium). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N. EPSS exploitation probability: 0.3%.

F Revocrm CVE-2023-41150

MEDIUM

Cross-site Scripting (XSS) (CWE-79)

2023-09-06 vultures@jpcert.or.jp

XSS F Revocrm

5.4

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

5.4 MEDIUM

AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

Low

User Interaction

Required

Scope

Changed

Confidentiality

Low

Integrity

Low

Availability

None

Lifecycle Timeline

CVE Published

Sep 06, 2023 - 13:15 nvd

MEDIUM 5.4

DescriptionNVD

F-RevoCRM 7.3 series prior to version7.3.8 contains a cross-site scripting vulnerability. If this vulnerability is exploited, an arbitrary script may be executed on the web browser of the user who is using the product.

AnalysisAI

F-RevoCRM 7.3 series prior to version7.3.8 contains a cross-site scripting vulnerability. Rated medium severity (CVSS 5.4), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified as Cross-Site Scripting (XSS) (CWE-79), which allows attackers to inject malicious scripts into web pages viewed by other users. F-RevoCRM 7.3 series prior to version7.3.8 contains a cross-site scripting vulnerability. If this vulnerability is exploited, an arbitrary script may be executed on the web browser of the user who is using the product. Affected products include: F-Revocrm.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Sanitize all user input, use Content-Security-Policy headers, encode output contextually (HTML, JS, URL). Use frameworks with built-in XSS protection.